ALG6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.800300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.217400E-01
Normal-vs-Stage2
4.571600E-02
Normal-vs-Stage3
7.276300E-03
Normal-vs-Stage4
5.120400E-01
Stage1-vs-Stage2
3.824600E-01
Stage1-vs-Stage3
7.996400E-02
Stage1-vs-Stage4
8.924200E-01
Stage2-vs-Stage3
5.080200E-02
Stage2-vs-Stage4
3.285800E-01
Stage3-vs-Stage4
1.342000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.115600E-02
Normal-vs-AfricanAmerican
1.763380E-01
Normal-vs-Asian
5.715700E-02
Caucasian-vs-AfricanAmerican
3.710400E-01
Caucasian-vs-Asian
9.863600E-01
AfricanAmerican-vs-Asian
3.846400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.581530E-02
Normal-vs-Female
9.434000E-02
Male-vs-Female
7.280000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.843500E-02
Normal-vs-Age(41-60Yrs)
2.832500E-02
Normal-vs-Age(61-80Yrs)
4.170400E-02
Normal-vs-Age(81-100Yrs)
1.274600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.343600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.522600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.552600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.645700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.431000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.378800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.770000E-02
Normal-vs-Daily Drinker
3.866000E-02
Normal-vs-Weekly Drinker
5.484100E-03
Normal-vs-Occasional Drinker
8.959700E-02
Normal-vs-Social Drinker
6.291500E-02
Non Drinker-vs-Daily Drinker
9.667600E-01
Non Drinker-vs-Weekly Drinker
1.914200E-01
Non Drinker-vs-Occasional Drinker
2.099000E-01
Non Drinker-vs-Social Drinker
2.911800E-01
Daily Drinker-vs-Weekly Drinker
2.405800E-01
Daily Drinker-vs-Occasional Drinker
2.342800E-01
Daily Drinker-vs-Social Drinker
3.112000E-01
Weekly Drinker-vs-Occasional Drinker
1.994460E-02
Weekly Drinker-vs-Social Drinker
2.735500E-02
Occasional Drinker-vs-Social Drinker
8.777000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.271600E-01
Normal-vs-Grade 2
6.348200E-01
Normal-vs-Grade 3
2.115800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.726400E-01
Grade 1-vs-Grade 3
4.768000E-01
Grade 1-vs-Grade 4
3.271600E-01
Grade 2-vs-Grade 3
7.584000E-01
Grade 2-vs-Grade 4
6.348200E-01
Grade 3-vs-Grade 4
2.115800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.266200E-02
Normal-vs-NonDiabetic
1.061690E-02
Diabetic-vs-NonDiabetic
6.490200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.629800E-02
Normal-vs-NoPancreatitis
1.810440E-02
Pancreatitis-vs-NoPancreatitis
9.629400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.912000E-02
Normal-vs-N1
3.944100E-02
N0-vs-N1
8.410800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.218950E-01
Normal-vs-TP53-NonMutant
1.787180E-01
TP53-Mutant-vs-TP53-NonMutant
9.689800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
